Fig. 1From: Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, SwedenHCV prevalence (%) in total and per registration year. All patients are analyzed based on their registration year, both those positive at registration and those negative at registration and positive at repeat testingBack to article page